MedPath

Saxagliptin

These highlights do not include all the information needed to use SAXAGLIPTIN TABLETS safely and effectively. See full prescribing information for SAXAGLIPTIN TABLETS. SAXAGLIPTIN tablets, for oral use Initial U.S. Approval: 2009

Approved
Approval ID

6e390c1b-a539-48f4-af32-24723121afb8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 8, 2022

Manufacturers
FDA

Amneal Pharmaceuticals LLC

DUNS: 123797875

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Saxagliptin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code65162-059
Application NumberANDA205941
Product Classification
M
Marketing Category
C73584
G
Generic Name
Saxagliptin
Product Specifications
Route of AdministrationORAL
Effective DateAugust 9, 2023
FDA Product Classification

INGREDIENTS (17)

HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
AMMONIAInactive
Code: 5138Q19F1X
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
SHELLACInactive
Code: 46N107B71O
Classification: IACT
SAXAGLIPTIN HYDROCHLORIDEActive
Quantity: 2.5 mg in 1 1
Code: Z8J84YIX6L
Classification: ACTIM

Saxagliptin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code65162-060
Application NumberANDA205941
Product Classification
M
Marketing Category
C73584
G
Generic Name
Saxagliptin
Product Specifications
Route of AdministrationORAL
Effective DateAugust 9, 2023
FDA Product Classification

INGREDIENTS (17)

CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
SHELLACInactive
Code: 46N107B71O
Classification: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
AMMONIAInactive
Code: 5138Q19F1X
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
SAXAGLIPTIN HYDROCHLORIDEActive
Quantity: 5 mg in 1 1
Code: Z8J84YIX6L
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Saxagliptin - FDA Drug Approval Details